Description
Syntex Pharma CJC-1295 is a peptide formulation containing CJC-1295, a growth hormone-releasing hormone (GHRH) analogue widely studied for its interaction with endogenous growth hormone secretion and endocrine signaling pathways. It is commonly researched for its potential role in growth hormone regulation, recovery, body composition, and metabolic function.
Each pack contains 5 vials, with 2 mg of CJC-1295 per vial, providing a total peptide content of 10 mg. Syntex Pharma CJC-1295 is supplied in a lyophilized format and is intended for research applications involving peptide science, endocrinology, and growth hormone studies.
Key Features
- CJC-1295 peptide formulation
- 2 mg per vial
- 5 vials per pack
- Total peptide content: 10 mg
- Lyophilized peptide format
- Studied for growth hormone-releasing hormone pathways
- Research-focused peptide compound
Contents
- Active Ingredient: CJC-1295 – 2 mg
- Quantity: 5 Vials
Reviews
There are no reviews yet.